How AI is Accelerating Drug Discovery and Vaccine Development
In a featured interview at with NBC Las Vegas, Phil Mounteney, VP of Science and Technology at Dotmatics, explores how AI is revolutionizing drug discovery and vaccine development. From accelerating research timelines to reducing costs and improving drug safety, AI is playing a pivotal role in reshaping the industry post-COVID.
Phil highlights how AI-driven data analysis helps researchers quickly identify promising drug candidates, predict potential safety risks, and optimize development pipelines—all contributing to faster, safer, and more efficient medical breakthroughs.
Watch the full interview to discover how Dotmatics is driving innovation in life sciences and learn how AI is shaping the future of drug discovery.
Learn More About Dotmatics
Schedule a meeting with our product experts today for a personalized demo of Luma's AI capabilities.